AstraZeneca plans to advance its three cancer drug candidates into Phase III trials. -More- …
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic c…
Determined to prove to investors that AstraZeneca has a late-stage game plan that can rescue the pharma company from a lengthy losing streak, the company today spotlighted plans to speed up the Phase…
LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its…
